Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A page revision/version identifier was updated from v3.5.2 to v3.5.3 on the study’s record history page.
    Difference
    0.1%
    Check dated 2026-04-24T04:31:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:32:23.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the Record History and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:50:24.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision v3.4.3 has been added to the history, and the v3.4.2 entry has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:56:15.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page history, and the previously displayed funding-lapse notice (v3.4.1) was removed. The overall interface and listed study records remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:24:12.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations. Introduced revision v3.4.1; the previous revision v3.4.0 is removed from the history.
    Difference
    0.5%
    Check dated 2026-02-04T05:51:31.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.